Scarica l'app Stockscreener
2.56
0.59%
0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.55
Aprire:
$2.53
Volume 24 ore:
477.76K
Relative Volume:
0.53
Capitalizzazione di mercato:
$130.83M
Reddito:
-
Utile/perdita netta:
$-32.94M
Rapporto P/E:
-2.3063
EPS:
-1.11
Flusso di cassa netto:
$-24.95M
1 W Prestazione:
+2.60%
1M Prestazione:
-2.84%
6M Prestazione:
-25.00%
1 anno Prestazione:
-42.36%
Intervallo 1D:
$2.4601
$2.58
Intervallo di 1 settimana:
$2.3708
$2.5889
Portata 52W:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Confronta ACHV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.56 | 129.81M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.18 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.02 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.85 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.36 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
319.45 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Are Bears Losing Grip on Achieve Life Sciences Inc.2025 Trading Recap & Real-Time Stock Price Movement Reports - beatles.ru
Achieve Life Sciences (NASDAQ:ACHV) Releases Earnings Results, Hits Estimates - MarketBeat
Achieve Life Sciences, Inc. shares rise 2.42% after-hours following positive earnings report. - AInvest
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q2 2025 Earnings Call Transcript - Insider Monkey
Achieve Life Sciences, Inc. shares rise 3.60% premarket after Deutsche Bank maintains 'buy' rating on Merck KGaA. - AInvest
ACHV: Second Quarter Results - MSN
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - 富途牛牛
When Will Achieve Life Sciences, Inc. (NASDAQ:ACHV) Turn A Profit? - Yahoo Finance
Achieve Life Sciences: Optimistic Outlook Driven by Strategic Advances and Financial Strength - AInvest
Optimistic Buy Rating for Achieve Life Sciences Driven by Strategic Advances and Financial Strength - TipRanks
Achieve Life Sciences Inc (ACHV) Q2 2025 Earnings Call Highlights: Strategic Moves and ... By GuruFocus - Investing.com Canada
Achieve Life Sciences Inc (ACHV) Q2 2025 Earnings Call Highlights: Strategic Moves and Financial Fortification - GuruFocus
Achieve Life Sciences shares fall 1.14% after-hours following Q2 earnings miss. - AInvest
Achieve (ACHV) Q2 Net Loss Hits $12.7M - AOL.com
Achieve Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Achieve Life Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Achieve Life Sciences Q2 2025 results match forecasts - Investing.com Australia
Achieve Life Sciences reports Q2 EPS (37c), consensus (35c) - TipRanks
Achieve Life Sciences reports Q2 EPS of 37c, beats consensus of 35c. - AInvest
Achieve Life Sciences Q2 loss per share misses estimates - MarketScreener
Achieve Life Sciences Reports Second Quarter 2025 Financial Resu - GuruFocus
ACHIEVE LIFE SCIENCES, INC. SEC 10-Q Report - TradingView
Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - GlobeNewswire
First New Smoking Cessation Drug in 20 Years: Achieve Life Sciences Submits FDA Application, Raises $49M - Stock Titan
Achieve Life Sciences Q2 Earnings Preview: Expected EPS -$0.35, Revenue $0M - AInvest
Achieve Life Sciences Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
What makes Achieve Life Sciences Inc. stock price move sharplyBreakthrough financial growth - Jammu Links News
Published on: 2025-08-04 07:45:21 - Jammu Links News
What are analysts’ price targets for Achieve Life Sciences Inc. in the next 12 monthsCapitalize on market trends early - Jammu Links News
Is Achieve Life Sciences Inc. stock overvalued or undervaluedHigh-velocity capital appreciation - Jammu Links News
What catalysts could drive Achieve Life Sciences Inc. stock higher in 2025Invest smarter and grow your wealth faster - Jammu Links News
What are the latest earnings results for ENDRA Life Sciences Inc.Achieve breakthrough investment performance - Jammu Links News
What analysts say about Achieve Life Sciences Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
Achieve Life Sciences (ACHV) to Release Earnings on Thursday - MarketBeat
What are the latest earnings results for SELLAS Life Sciences Group Inc.Achieve fast wealth growth with smart picks - Jammu Links News
How volatile is Achieve Life Sciences Inc. stock compared to the marketCapitalize on market momentum for maximum gains - Jammu Links News
What is Achieve Life Sciences Inc. company’s growth strategyBuild a portfolio with strong long-term growth - Jammu Links News
How does Achieve Life Sciences Inc. compare to its industry peersDiscover high-return stocks for your portfolio - Jammu Links News
What institutional investors are buying ReShape Lifesciences Inc. stockAchieve breakthrough financial results - Jammu Links News
What institutional investors are buying Achieve Life Sciences Inc. stock - Jammu Links News
Why is Achieve Life Sciences Inc. stock attracting strong analyst attentionStock Strategy Signals For Smart Trading - Jammu Links News
BTIG Virtual Biotechnology Conference: Achieve Life Sciences to Present Cytisinicline for Nicotine Dependence Treatment - AInvest
Achieve Life Sciences shares rise 2.75% premarket after announcing participation in the BTIG Virtual Biotechnology Conference. - AInvest
Momentum divergence signals in Achieve Life Sciences Inc. chartStrong Buy Opportunity with Volume Support - Newser
Can Traders Expect Breakout From Achieve Life Sciences Inc. This WeekStock Screener With Smart Filters Highlights Top Picks - metal.it
Achieve Life Sciences shares rise 1.96% after-hours after announcing participation in the BTIG Virtual Biotechnology Conference. - AInvest
BTIG Boosts Adaptive Biotechnologies Price Target to $13 Amid Optimism in Diagnostics Sector - AInvest
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire
Achieve Life Sciences to Participate in BTIG Virtual Biotechnology Conference on July 29-30, 2025 - Quiver Quantitative
Achieve Life Sciences Reveals Latest Progress on Revolutionary Smoking Cessation Drug at BTIG Biotech Conference - Stock Titan
Published on: 2025-07-29 13:59:03 - metal.it
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stewart Richard Alistair | Chieve Executive Officer |
Mar 17 '25 |
Buy |
2.86 |
10,000 |
28,598 |
60,876 |
0.06%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):